Brain protection device during heart valve replacement
Part of Heart & circulation clinical trials.
This study tests a new device (the EMBLOK system) that is placed in the aorta during TAVR to catch small debris that might travel to the brain and cause a stroke. If you're having TAVR, the study compares using this protection device to not using it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You are eligible for a TAVR procedure (heart valve replacement) done through the leg
- You have not had a stroke or mini-stroke in the last 6 months, and no prior stroke that caused major disability
- Your kidney function is adequate (not severe kidney failure and not on dialysis)
- You can undergo an MRI scan of your brain (no non-MRI-compatible pacemaker or metal clips)
- You don't have any other planned heart surgery or major procedure within 10 days of the TAVR
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device (EmStop) that helps protect your brain during TAVR (a type of heart valve replacement). The device is placed in arteries to catch any debris that might break loose during the procedure, potentially reducing the risk of stroke.
This trial is testing a new device called POINT-GUARD that is used during TAVR (a procedure to replace a heart valve). It aims to see if the device can safely catch any debris or particles that might travel to the brain during the procedure.
This study tests if a special device placed during transcatheter aortic valve replacement (TAVR) can help prevent stroke. It is for adults with severe aortic stenosis who are already scheduled for TAVR.
This trial tests a new filter device designed to catch debris that might travel to the brain during a minimally invasive aortic valve replacement (TAVR). The goal is to see if it can help reduce the risk of stroke.
This trial tests a new device called CHORDS that protects your brain during transcatheter aortic valve replacement (TAVR), a minimally invasive procedure to fix a narrow aortic valve. The device works by blocking debris that might travel to your brain during the procedure.
This early feasibility study tests a device filter system used during a TAVR procedure to help protect the brain and other organs from debris that can break free. It looks mainly at whether the filter can be safely placed and delivered as planned.
Hear when a new Aortic Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.